Difference: AdvDrugdisc (4 vs. 5)

Advances in Drug Discovery ACS meeting 2005

October 16 -19,2005 1 Pennsylvania Convention Center  Philadelphia, PA 
 
Morning Session 

Topic -Structural Biology in Drug Discovery 
Chuck Reynolds, Johnson & Johnson 
Sir Tom Blundell, Cambridge Un~versity 
Lance Stewart, decode Biostructures 
Break 
Robert Kaptein, Utrecht University 
Chaohong Sun, Abbott Laboratories 

 Topic -Structure Based ADME-Tox 
Marcel Verdonk, Astex Therapeutics 
Brett Tounge, Johnson & Johnson 
Break 
Jim Wells, Sunesls 
QuaolinDeng, Merck 


Morning Session 
Topic -Modeling Methodology in Structure-Based Design
 8:30AM -8:45AM Dagmar Ringe, Brandeis University 
8:45AM -9:30AM William Jorgensen, Yale Univerisity 
9:30AM -10:15AM Bertrand Garcia-Moreno, Johns Hopkins University 
l0:15AM -10:30AM Break 1
0:30AM -11 :15AM John Moult, University of Maryland 
11:15AM -12:OOPM Frank Guarnieri, Phase II Pharmaceuticals, Inc. 

Afternoon Session Topic: Application of Structure-Based Design in Drug Discovery (
 Erin Duffy, Rib-X 
Eddy Arnold, Rutgers University 
Deborah Loughney, EMS Break 
Jeffrey Wiseman, Locus Pharmaceuticals 
William Carlson, Thrasos Therapeutics 

Oral Presentation of Selected Posters 


Morning Session Topic -Structure-Driven Medicinal Chemistry 
8:15AM -8:30AM Kenneth Merz, University of Florida 
8:30AM -9:15AM Bruce Maryanoff, Johnson &Johnson 

9:15AM -10:OOAM Joseph Vacca, Merck 
10:OOAM -10:15AM Break 
10:15AM -11:OOAM Jack Baldwin, Vitae Pharmaceuticals 
11:OOAM -12:OOPM Irwin "Tack" Kuntz, University of California



   * Set ALLOWTOPICVIEW = 

-- Main.DavidCowburn - 09 Nov 2005